What are the considerations for administering upadacitinib through a feeding tube?

Read full text Summarise with VIRAT
Authors: Tripdatabase
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

The use of upadacitinib through feeding tubes should primarily consider liquid formulations to maintain safety and efficacy, avoiding solid forms which require alteration.

Fields of Study & Subjects

Clinical Nutrition and Gastroenterology Rheumatoid Arthritis Research and Therapies Pharmaceutical studies and practices

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
20 March 2026
Language
EN